Syngene International to host Q1 FY27 earnings call on July 30

1 min read Updated on 22 Jul 2026, 08:31 PM

Reviewed by

Shriram SScanX News Team

AI Summary

Syngene International Limited has announced a conference call on July 30, 2026, at 9:00 AM IST to discuss its Q1 FY2027 financial results. The call will include a management presentation and a Q&A session. Replay and transcript facilities will be available on the company's website shortly after the event.

*this image is generated using AI for illustrative purposes only.

Syngene International Limited will host a conference call on July 30, 2026, to discuss its financial results for the quarter ended June 2026. The earnings call, scheduled for 9:00 AM IST, will provide analysts and investors with an overview of the company's performance in Q1 FY2027. The session will begin with a brief management discussion followed by an interactive Question & Answer session.

The event follows the announcement of the company's financial results for the first quarter of the fiscal year 2026-27. Participants can join the discussion via dial-in numbers or a webcast link. The company has also provided a pre-registration facility to streamline the connection process for attendees.

Conference Call Details

Feature	Details
Date	Thursday, July 30, 2026
Time	9:00 am to 10:00 am IST
Primary Number	+91 22 6280 1279 / +91 22 7115 8180
USA Number	18667462133
UK Number	08081011573
Singapore Number	8001012045
Hong Kong Number	800964448
Australia Number	0080014243444

Access and Replay Options

Participants can join the webcast directly via the provided link. For those unable to attend the live session, a replay facility will be available. The audio replay can be accessed by dialing +91 22 71945757 and using Playback ID 48209#. This facility will be accessible from July 30, 2026, until August 5, 2026. Additionally, the audio recording and a transcript of the conference call will be made available on the corporate website within seven working days of the event.

Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, and specialty chemical sectors. The company operates over 3 million sq. ft of specialized facilities across India and the U.S.

Historical Stock Returns for Syngene International

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.66%	-3.11%	-8.34%	-32.36%	-39.44%	-35.26%

What key performance indicators should investors focus on during the Q1 FY2027 earnings call?

How might Syngene's financial results impact its stock price in the short term?

What strategic initiatives is Syngene likely to highlight for the upcoming fiscal year?

Read Next Article

Syngene International accepts General Counsel resignation

1 min read Updated on 15 Jul 2026, 10:05 AM

Reviewed by

Ashish TScanX News Team

Add as a preferred
source on Google

AI Summary

Syngene International has accepted the resignation of Surender Sharma as General Counsel and Executive Committee member, effective July 15, 2026. The resignation follows a mutual decision as Sharma pursues other career opportunities. The disclosure was made under SEBI LODR regulations.

*this image is generated using AI for illustrative purposes only.

Syngene International has accepted the resignation of Surender Sharma as General Counsel and a member of its Executive Committee. The resignation is effective from the close of business hours on July 15, 2026, following a mutual decision between the executive and the company. Sharma is departing to pursue other career opportunities, marking a change in the company's senior management personnel structure.

The disclosure was made to the stock exchanges pursuant to Regulation 30 read with Para A (7) of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the departure is by mutual consent and that all necessary procedural details have been submitted to the exchanges.

The table below summarizes the key details regarding the change in senior management personnel:

S. No.	Particulars	Details
1.	Reason for change	Leaving by mutual consent to pursue other career opportunities
2.	Date of cessation	Effective from close of business hours on July 15, 2026
3.	Brief profile	Not Applicable
4.	Disclosure of relationships	Not Applicable

Chethan Yogesh, Company Secretary & Compliance Officer of Syngene International, signed the regulatory filing on July 14, 2026. The information regarding this change in senior management has been made available on the company's official website.

Historical Stock Returns for Syngene International